ArticleWorld journal of microbiology & biotechnology2026
Bacillus sp. Z26 suppresses Alternaria alternata and its mycotoxins by targeting AaPex13-mediated peroxisome biogenesis.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Alternaria alternata is a destructive postharvest pathogen that causes fruit decay and produces multiple mycotoxins, including alternariol (AOH), alternariol monomethyl ether (AME), and tenuazonic acid (TeA), posing a serious threat to crop quality and food safety. Biocontrol stands out as a promising strategy to mitigate both fungal infection and mycotoxin production. This study investigated that Bacillus sp. Z26 effectively inhibits the mycelial growth and mycotoxin accumulation of A. alternata. Comparative transcriptomic analysis revealed that strain Z26 did not directly repress canonical mycotoxin biosynthetic gene clusters; instead, it caused extensive transcriptional reprogramming in amino acid and lipid metabolism, with peroxisome-associated pathways being prominently affected. Among the downregulated genes, AaPex13 was identified as a key peroxisome biogenesis factor potentially involved in the biocontrol process. Targeted deletion of AaPex13 significantly impaired vegetative growth, conidiation, stress tolerance, and pathogenicity of A. alternata. Notably, loss of AaPex13 almost abolished TeA biosynthesis, while only partially reducing AOH and AME accumulation, indicating distinct metabolic dependencies among these toxins. In parallel, Bacillus sp. Z26 directly and selectively degraded AOH and AME, but not TeA. In grape berry assays, strain Z26 reduced disease severity, lowered mycotoxin contamination, and induced host defense responses, as evidenced by enhanced PPO and PAL activities and increased trans-resveratrol accumulation. Collectively, these findings suggest that Bacillus sp. Z26 suppresses A. alternata through a multifaceted mechanism involving disruption of AaPex13-mediated peroxisome biogenesis, selective detoxification of AOH and AME, and activation of host resistance. This study highlights peroxisome biogenesis as a previously underappreciated vulnerability in A. alternata and provides a potential target for precision biocontrol of Alternaria-associated postharvest diseases and mycotoxin contamination.
Indexed as
Identifiers
42406189What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.